Shenzhen Salubris Pharmaceuticals Co Ltd (002294):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shenzhen Salubris Pharmaceuticals Co Ltd (002294) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8102
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shenzhen Salubris Pharmaceuticals Co Ltd (Salubris) is a pharmaceutical company that research, develops, manufactures and distributes pharmaceutical and healthcare products. The company produces tablet, capsule, and injection formulations and active pharmaceutical ingredients, among others. Salubris’ products include clopidogrel hydrogensulfate, desloratadine, benazepril hydrochloride and azithromycin dispersible tablets, among others. The company provides cefuroxime sodium injection, cefepime hydrochloride injection, cefoxitin injection, cefonicid sodium injection, cefoperazone + sulbactam injection, cefotaxime sodium injection, ceftazidime injection, cefoperazone sodium injection, cefazolin sodium injection and cefradine injection, among others. It offers cefuroxime sodium sterile, cefepime hydrochloride sterile, cefepime HCL+L-arginine sterile, cefoxitin sodium sterile, cefonicid sodium sterile, clopidogrel hydrogensulfate, desloratadine and benazepril hydrochloride, among others. The company operates through its branches and marketing network in different parts of the country. Salubris is headquartered in Shenzhen, China.

Shenzhen Salubris Pharmaceuticals Co Ltd (002294) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shenzhen Salubris Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Shenzhen Salubris Pharma Forms Healthcare Joint Venture 11
Shenzhen Salubris To Form Joint Venture With Shanghai Pharma Company 12
Licensing Agreements 13
Salubris Biotherapeutics to Enter into Licensing Agreement with National Institutes of Health 13
Shenzhen Salubris Pharma Enters Into Licensing Agreement With Shanghai Fosun Pharma For Diabetes Drug 14
Equity Offering 15
GO Therapeutics Raises USD5 Million in Private Placement 15
Acquisition 16
Shenzhen Salubris Pharma to Acquire 10.81% Stake in Changshu-Based Biotech Company 16
Shenzhen Salubris Pharma Acquires Minority Stake in Suzhou Based Biotech Company for USD23.5 Million 17
Shenzhen Salubris Pharma Acquires 80% Stake in Chengdu Based Biotech Company 18
Shenzhen Salubris Pharma Acquires 24.06% Stake in Suzhou Based Biotech Company 19
Shenzhen Salubris Pharma to Acquire Shenzhen-Based Pharma Company for USD0.33 Million 20
Shenzhen Salubris Pharmaceuticals Co Ltd – Key Competitors 21
Shenzhen Salubris Pharmaceuticals Co Ltd – Key Employees 22
Shenzhen Salubris Pharmaceuticals Co Ltd – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shenzhen Salubris Pharmaceuticals Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Shenzhen Salubris Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Shenzhen Salubris Pharma Forms Healthcare Joint Venture 11
Shenzhen Salubris To Form Joint Venture With Shanghai Pharma Company 12
Salubris Biotherapeutics to Enter into Licensing Agreement with National Institutes of Health 13
Shenzhen Salubris Pharma Enters Into Licensing Agreement With Shanghai Fosun Pharma For Diabetes Drug 14
GO Therapeutics Raises USD5 Million in Private Placement 15
Shenzhen Salubris Pharma to Acquire 10.81% Stake in Changshu-Based Biotech Company 16
Shenzhen Salubris Pharma Acquires Minority Stake in Suzhou Based Biotech Company for USD23.5 Million 17
Shenzhen Salubris Pharma Acquires 80% Stake in Chengdu Based Biotech Company 18
Shenzhen Salubris Pharma Acquires 24.06% Stake in Suzhou Based Biotech Company 19
Shenzhen Salubris Pharma to Acquire Shenzhen-Based Pharma Company for USD0.33 Million 20
Shenzhen Salubris Pharmaceuticals Co Ltd, Key Competitors 21
Shenzhen Salubris Pharmaceuticals Co Ltd, Key Employees 22
Shenzhen Salubris Pharmaceuticals Co Ltd, Subsidiaries 23

List of Figures
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shenzhen Salubris Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shenzhen Salubris Pharmaceuticals Co Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Shenzhen Salubris Pharmaceuticals Co Ltd (002294):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oxford BioTherapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford BioTherapeutics Ltd (OBT) is a clinical stage oncology company that develops antibody drug conjugates for the treatment of variety of cancers. The company’s product pipelines currently includes T-cell based IO therapies including check point modulators; NK cell based IO therapies such …
  • Shv Holdings N.V.
    Shv Holdings N.V. - Strategy, SWOT and Corporate Finance Report Summary Shv Holdings N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • G M Breweries Ltd:企業の戦略・SWOT・財務分析
    G M Breweries Ltd - Strategy, SWOT and Corporate Finance Report Summary G M Breweries Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Gujarat Industries Power Co Ltd (GIPCL):企業の財務・戦略的SWOT分析
    Gujarat Industries Power Co Ltd (GIPCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Graphic Packaging Holding Company:企業の戦略・SWOT・財務情報
    Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report Summary Graphic Packaging Holding Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • JHL Biotech Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary JHL Biotech Inc (JHL Biotech) is a biologic medicines provider. The company offers cell line construction, process development, manufacturing, quality and regulatory services. It offers products such as biosimilar rituximab, biosimilar dornase alfa, biosimilar bevacizumab, biosimilar trastuz …
  • MAXIMUS Inc (MMS):企業の財務・戦略的SWOT分析
    MAXIMUS Inc (MMS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Mologen AG (MGN):企業の財務・戦略的SWOT分析
    Summary Mologen AG (Mologen) is a biotechnology company that offers research and clinical development of novel drugs, immunotherapies and active ingredients. The company develops various pipeline products such as MGN1703, MGN1601, MGN1404, MGN1331 and MGN1333. It uses proprietary platform technologi …
  • Vivendi SA (VIV):企業の財務・戦略的SWOT分析
    Vivendi SA (VIV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tempur Sealy International, Inc. (TPX):企業の財務・戦略的SWOT分析
    Tempur Sealy International, Inc. (TPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • sanofi-aventis US LLC-製薬・医療分野:企業M&A・提携分析
    Summary Sanofi-Aventis US LLC (Sanofi US), a subsidiary of Sanofi is a drug company that discovers, develops and distributes various therapeutic solutions. The company provides prescription products, vaccines and other products. Sanofi US’s vaccines include ActHIB, Adacel, DAPTACEL, Decavac, Fluzone …
  • Antero Resources Corp (AR):企業の財務・戦略的SWOT分析
    Antero Resources Corp (AR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Eni S.p.A:企業の戦略・SWOT・財務情報
    Eni S.p.A - Strategy, SWOT and Corporate Finance Report Summary Eni S.p.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • GW Pharmaceuticals Plc (GWP):製薬・医療:M&Aディール及び事業提携情報
    Summary GW Pharmaceuticals Plc (GW Pharmaceuticals) is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary cannabinoid product platform. The company’s commercialized product, Sativex is a plant-derived cannabinoid prescription drug, for the …
  • Dataprep Holdings Berhad (DATAPRP):企業の財務・戦略的SWOT分析
    Dataprep Holdings Berhad (DATAPRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Netcare Limited:企業の戦略・SWOT・財務情報
    Netcare Limited - Strategy, SWOT and Corporate Finance Report Summary Netcare Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • AB Science SA (AB):企業の財務・戦略的SWOT分析
    Summary AB Science SA (ABS) is a pharmaceutical company focused on discovery, development, and commercialization of protein kinase inhibitors. The company's lead compound Masitinib, is a orally administered tyrosine kinase inhibitor targeting mast cells and selected kinases, including c-Kit, PDGFR, …
  • United Continental Holdings Inc:戦略・SWOT・企業財務分析
    United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary United Continental Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • China Resources Enterprise Ltd:企業の戦略的SWOT分析
    China Resources Enterprise Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Tokyo Electric Power Company Holdings Incorporated:発電所・企業SWOT分析
    Tokyo Electric Power Company Holdings Incorporated – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆